Controversy continues over when physicians should declare brain death, NPR reported.
The EPA released a new draft report affirming the safety of paraquat, saying the evidence tying Parkinson’s disease in humans to paraquat exposure from pesticide use was insufficient.
Meanwhile, the BBC said that U.K.-based paraquat pesticide maker Syngenta may have underreported Parkinson’s in documents used in legal action brought by U.S. farmers.
Artificial intelligence (AI) improved the diagnostic accuracy in monitoring amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients treated with aducanumab (Aduhelm) in clinical trials. (JAMA Network Open)
Motor outcomes seen with 6 mg/kg/day of vamorolone (Agamree) at 24 weeks in boys with Duchenne muscular dystrophy were maintained to 48 weeks of treatment. (Neurology)
Limiting screen time and returning to school early were linked with faster symptom resolution after concussion in adolescents. (British Journal of Sports Medicine)
The Bruton tyrosine kinase inhibitor evobrutinib reduced slowly-expanding lesion volume in relapsing multiple sclerosis in a dose-dependent manner, a post-hoc analysis of phase II trial data showed. (Neurology)
Brain dynamic functional connectivity was atypical in preterm-born infants and associated with social, sensory, and repetitive behaviors at age 18 months. (Nature Communications)
Physical activity postponed cognitive decline to a very small extent, a meta-analysis showed. (JAMA Network Open)
The American Academy of Neurology issued a position statement on prescription drug prices, saying action is needed to ensure effective medications are accessible for people with complex, chronic neurologic conditions. (Neurology)
Please enable JavaScript to view the